APR 20, 2022 11:00 AM PDT

Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness

WRITTEN BY: Ryan Vingum

Dendritic cells play an important role in the immune system. Specifically, they help gather up antigen-presenting cells (or APCs) and present them to other cells in the immune system, such as T cells. In doing so, they help trigger a response from the immune system.

The activity of dendritic cells can play a crucial role in certain types of immunotherapy treatments for cancer, as well. Dendritic cell-based therapies, for example, work to train dendritic cells to recognize tumor-specific antigens. In theory, this gives the body tools it needs to detect and fight cancer cells on its own. These treatments can help overcome obstacles the body faces with cancer; for example, tumors can trick and confuse dendritic cells that might be able to destroy it, weakening the body’s natural defenses. 

In a new retrospective study, researchers concluded that vitamin E, specifically, plays an important role in conditioning dendritic cells and invigorating them, improving patient response to different kinds of immunotherapy. Researchers reviewed data from patients who had received immunotherapy at MD Anderson Hospital. Results from the analysis are published in Cancer Discovery

Vitamin E offers a lot of health benefits, though it primarily works as an antioxidant that helps reduce the amount of reactive oxygen species produced when fat is oxidized. It’s found naturally in a range of plant-based foods, nuts, and fruits and veggies.

From their analysis, researchers found that vitamin E may play a crucial role in preventing some of the regulatory checkpoints in dendritic cells from activating. Specifically, it appears vitamin E binds to the SHP1 protein, which is a key regulatory checkpoint in dendritic cells. By preventing this regulatory marker from activating, dendritic cells could activate and encourage more T cell development and disbursement throughout the body, boosting the body’s immune response. 

Researchers believe these findings point towards new directions for dendritic-based immunotherapies in the future. Not only did they find that vitamin E boosted immunity, but findings also suggested that the SHP1 protein could be a viable therapeutic target in future therapies. 

Sources: Science Daily, Cancer Discovery

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
MAR 14, 2022
Cancer
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
MAR 14, 2022
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
Over the past decade, immunotherapy drugs known as immune checkpoint inhibitors have emerged as a promising an ...
APR 08, 2022
Drug Discovery & Development
Puberty-triggering Hormone Reverses Fatty Liver Disease in Mice
APR 08, 2022
Puberty-triggering Hormone Reverses Fatty Liver Disease in Mice
Kisspeptin, a hormone that triggers puberty and regulates fertility in humans, may be able to treat non-alcoholic fatty ...
APR 20, 2022
Immunology
Rare Soil Microbe Shows Promise as New Antibiotic
APR 20, 2022
Rare Soil Microbe Shows Promise as New Antibiotic
  Antibiotic resistance has increased the demand for new antibiotic treatments. Now, researchers have found that a ...
APR 21, 2022
Drug Discovery & Development
No Link Between Antidepressants and Improved Quality of Life
APR 21, 2022
No Link Between Antidepressants and Improved Quality of Life
Those who use antidepressant medications have a similar health-related quality of life to people who are depressed and w ...
APR 22, 2022
Health & Medicine
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
APR 22, 2022
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
A new study published in Frontiers examined the influence of acute and chronic cannabis use on stress regulation. Althou ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
Loading Comments...